Establishment of the Barrett coordination center

The NKI Center for Early Diagnostics and the Dutch Barrett’s Registry Foundation (NBRS) are joining forces to establish the Barrett coordination center to further improve care for patients with Barrett’s esophagus.

Updated Barrett guideline

The Dutch guideline for patients with Barrett’s esophagus has been revised as of March 1, 2025, meaning that patients with low-risk Barrett’s esophagus no longer need regular endoscopic screening, as it does not contribute to health and may carry risks and disadvantages.

National Barrett registry

Low-risk Barrett’s patients are registered with the Barrett coordination center for inclusion in a National Barrett Registry, to gain a greater understanding of Barrett’s esophagus. This registry also enables future contact if new insights emerge. This initiative is part of a nationwide project by the Dutch Society of Gastroenterology (NVMDL) in collaboration with ZorgEvaluatie & Gepast Gebruik.

Role of the Barrett coordination center

The Barrett coordination center plays a central role in the coordination of:

Patient registrations
Data collection and registration with patient consent
Support for healthcare providers and patients throughout the Netherlands

For more information about this project and the registry:
👉 www.barrett.nl

One year of the prostate consultation: promising results in early detection of prostate cancer

The initial results after one year of the Prostate Consultation, a collaboration between the NKI Center for Early Diagnostics and SALT, are promising. These results show that the Prostate Consultation is a valuable addition to primary care and that early detection can be implemented safely and efficiently.

Prostate cancer awareness month: know your risk

Did you know that men of Surinamese, Caribbean, and African ancestry have a higher risk of developing prostate cancer? And that the disease often develops more aggressively in these men? This makes early detection vital, even before symptoms occur.

Improving prostate cancer risk assessment using abdominal ultrasound

Over the past year, researchers at the NKI Center for Early Diagnostics have been investigating a new, more patient-friendly method to assess the risk of prostate cancer in men with elevated PSA levels. The first promising results of this study were recently published in the scientific journal The Prostate.

NKI expands its collaboration with Andros Clinics

The Netherlands Cancer Institute and Andros Clinics are intensifying their collaboration to help men with an increased risk of prostate cancer more quickly and effectively. Together, we ensure that every man is directed to the place that best matches his situation as quickly as possible. This not only improves the quality of care but also ensures that patients receive help faster.

Skin cancer awareness at Stichting Gouden Handen

Dermatologist Dr. Nicole Kukutsch from the NKI Center for Early Diagnostics has recently provided an inspiring lecture on skin cancer in the southeast region of Amsterdam. This lecture las been organized by Stichting De Gouden Handen, a foundation dedicated to opening up conversation on cancer within multicultural communities. A valuable initiative that we wholeheartedly support.

Prostate cancer is now the most common cancer type among men

Prostate cancer is now the most common form of cancer among men. Recent figures from the IKNL show that the disease is diagnosed almost as often as breast cancer, with over 15,000 new cases in the Netherlands in 2024. The number of men with prostate cancer is expected to increase further in the coming decades, mainly due to the aging population.

Four New Grants for Early Detection Research

Four research teams from the NKI Center for Early Diagnostics have been awarded funding for new projects to improve the early detection of cancer. These initiatives are made possible by financial support from the Dutch Cancer Society (KWF Kankerbestrijding) and donations from the DNA Benefit Gala. The studies are expected to significantly boost efforts in early cancer detection.